Robert Moss is an esteemed leader in international pharmacy. His passion for improving patient care, educating hospital pharmacists and other professional staff, and optimizing health systems through the integration of new IT and eHealth technologies has improved hospital pharmacy services and patient outcomes throughout Europe and globally.
As the current Vice President of the International Pharmaceutical Federation (FIP), Moss contributes to the improvement of hospital pharmacy services and patient health outcomes on an international level. A Fellow of FIP, he is the Immediate Past President of the FIP Hospital Pharmacy Section Executive Committee and previously served as director of professional development in the Board of the European Association of Hospital Pharmacists (EAHP) and as a board member for the Dutch Association of Hospital Pharmacists. He currently sits on the ASHP International Accreditation Commission.
Moss is an expert on medication shortages and substandard and falsified medication regulation. In his role within FIP he is the liaison to the FIP Technology Advisory Group, the Humanitarian Resilience Advisory Group and co-liaison to the African Pharmaceutical Forum. He was trained as a hospital pharmacist in Haarlem, The Netherlands and has worked in clinical settings throughout this career. He was head of pharmacy at LangeLand Hospital in the Hague and later became director of pharmacy at Farmadam, a facility serving 6,000 beds in the Amsterdam region specializing in pharmaceutical care for geriatric and mentally disabled patients. Moss now works as a consultant in hospital pharmacy. At the national level, he contributes to a program aiming to enable nationwide exchange of medicines and medication related data between all healthcare settings. Most recently, as part of his work as senior advisor of critical event preparedness for the Dutch National Medicines Coordination Center he focused on standardizing a critical medicines list for the Netherlands and links to the critical medicines lists at EU level.